BioCatalyst

Osimertinib, Cisplatin or Carboplatin; Pemetrexed or Paclitaxel, Radiation — catalyst calendar

1 verified catalyst event(s) referencing Osimertinib, Cisplatin or Carboplatin; Pemetrexed or Paclitaxel, Radiation, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-07-07
in 15d
ESTIMATED
 READOUT
To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of i
Phase 2 · Lung Cancer
 AZN ASTRAZENECA PLC Osimertinib, Cisplatin or Carboplatin; P ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.